Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

vituximab toward later-stage clinical trials. Planning for this exciting next phase for our bavituximab oncology program has already begun."

Mr. King added, "This past year we also made significant advancements in our bavituximab and broader anti-PS anti-viral program, receiving high-profile international validation through the publication of data in the highly respected scientific journal Nature Medicine, which confirmed the anti-viral potential of bavituximab and our other anti-PS antibodies. We were also successful in completing contract negotiations with the DTRA, allowing us to expand the evaluation of our anti-PS antibodies as potential broad spectrum agents for the treatment or prevention of viral hemorrhagic fever virus infections. This contract directly or indirectly supports our bavituximab and other anti-PS technology programs and represents another significant validation for the anti-PS technology platform."

Mr. King continued, "Our Cotara clinical program continues to advance with patient enrollment nearing completion in our dose confirmation and dosimetry study in patients with recurrent glioblastoma (GBM), and enrollment exceeds the halfway mark in our Phase II trial in relapsed GBM patients. We recently presented dosimetry study data at the Society of Nuclear Medicine 2009 Annual Meeting, further confirming that Cotara specifically localizes to brain tumors at high concentrations with minimal radiation exposure to other organs, reinforcing its potential as a possible new treatment for GBM."

At April 30, 2009, Peregrine had $10 million in cash and cash equivalents, compared to $15.1 million in cash and cash equivalents at April 30, 2008. After the close of the 2009 fiscal year, Peregrine raised approximately $6.9 million in gross proceeds from the sale of common stock from its existing shelf registration. The stock was sold in an "At the Market" offering as defined in Rule 415
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Georgia (PRWEB) July 29, 2014 Just ... expanding offices to 4 new states, the exciting FX ... Special FX and one time farmboy from Arkansas, is ... of bringing innovative event technologies to the masses. ... the event packed island of Jamaica. This new ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Helping people ... an immensely complex challenge that requires deep knowledge of ... to improve therapeutic options and outcomes has been the ... of biomedical engineering, since he joined the NJIT faculty ... significance is underscored by substantial funding from sources such ...
(Date:7/29/2014)... 29, 2014 A new 3-part video ... 2014 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific ... week. The videos review the benefits of ACE accreditation ... the cardiac catheterization laboratory from the perspective of clinicians ... video, Jane Kiah, MS, RN, Director of Cardiac and ...
(Date:7/29/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- Quitting smoking is ... review. Depression can make it more difficult to ... come with trying to quit cold turkey, scientists found. But ... people quit faster, they said. "The review should be ... Moullec, a postdoctoral researcher in the department of exercise science ...
(Date:7/29/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... J. Bowers, PhD, RN, FAAN, of the University of ... on Minority Issues in Gerontology Outstanding Mentorship Award. , ... who has exemplified outstanding commitment and dedication to mentoring ... award presentation will take place at GSA,s 67th Annual ...
Breaking Medicine News(10 mins):Health News:Atlanta Special FX Rapidly Expanding Just Opens First International Corporate Office in Jamaica 2Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Bowers to receive GSA's 2014 Minority Mentorship Award 2
... NORCROSS, Ga., Aug. 12 With the Centers for Disease ... of serious illnesses in school-age children (ages 5-24) and pregnant women ... can kill the virus immediately and continue to kill it for ... getting swine flu or avoiding it, especially before a vaccine is ...
... MINNEAPOLIS, Aug. 12 Twin Cities Orthopedics ... today announced a partnership with Surgical Care Affiliates (SCA) to develop ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080812/CLTU111LOGO ) , , ... be located at 4010 65th Street West Edina, Minnesota. In ...
... , , SAN ... in the field of remote patient monitoring, today announced that ... versions of the BlackBerry(R) Bold(TM), Tour(TM), Curve(TM) and 8800 ... for release this fall. , , ...
... , KENSINGTON, Md., Aug. 12 The ... a two-track contest united by a theme of helping psoriasis ... videos that will motivate psoriasis patients to resist the social ... and to engage with others with psoriasis and psoriatic arthritis ...
... cells, forcing remission, study says, , WEDNESDAY, Aug. ... suppresses the immune system to put multiple sclerosis ... Canadian scientists say. , In MS, the immune ... treatment, called GIFT15, is composed of two proteins, ...
... French . , Montreal, August 12, 2009 Sounds and ... to a new Canadian study. In the online edition of the ... ), scientists from the Universit de Montral and the Montreal Neurological ... the brain allows people to distinguish between different types of sounds, ...
Cached Medicine News:Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 2Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 3Health News:School-Age Children, Pregnant Women and Health Care Workers: Take Swine Flu Precautions by Washing with Cleanser that Kills Virus for Up to Six Hours 4Health News:Twin Cities Orthopedics to Partner with Surgical Care Affiliates 2Health News:AirStrip Technologies Releases AirStrip OB for BlackBerry 2Health News:AirStrip Technologies Releases AirStrip OB for BlackBerry 3Health News:Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 2Health News:Scientists Reverse Multiple Sclerosis in Mice 2Health News:Human mind: Sound and vision wired through same 'black box' 2
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... According to a new market ... Market (Neurosurgical Navigation Systems, ENT Navigation Systems and Orthopedic ... Trends and Forecast, 2014 - 2020", the global surgical ... in 2013 and is expected to grow at a ... an estimated value of USD 295.5 million in 2020. ...
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
Breaking Medicine Technology:Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 2Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 3Surgical Navigation Systems Market Expected to Reach USD 295.5 Million Globally in 2020: Transparency Market Research 4ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3
... Ill. , March 14 NorthShore University HealthSystem (NorthShore) ... the American College of Cardiology annual scientific sessions from the EVEREST ... novel, first-in-class catheter-based device,  is a safe and effective alternative to ... ...
... March 12 HEI, Inc. (Pink Sheets: HEII) ... has achieved qualification to MIL-P-50884E.  This qualification was awarded ... Agency.  DSCC manages Military qualifications for the electronics industry. ... Tempe, Arizona to manufacture rigid-flex and flex ...
Cached Medicine Technology:Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 2Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 3Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 4HEI, Inc. Announces Qualification to MIL-P-50884E 2
... enclosures are designed for ... other process gas to ... HEPA filtration, heating/cooling, humidification, ... also available, along with ...
... removes chemical fumes, allowing safe ... charcoal filters remove most organic ... exhaust flow speed = 100 ... Includes air speed monitor, quick-release ...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... These corrosion proof polypropylene exhaust hoods are ... of tanks and draw a stream of ... away from the operator. Other sizes and ... lateral, and double-slot are available on special ...
Medicine Products: